Currently out of the existing stock ratings of James Shin, 23 are a BUY (45.1%), 28 are a HOLD (54.9%).

James Shin

Work Performance Price Targets & Ratings Chart

Analyst James Shin, currently employed at DEUTSCHE BANK, has had 76.15% of price targets met with an average potential upside of 23.62%, reached in 198 days on average.

James Shin has documented 102 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GILD, Gilead Sciences at 26-Mar-2026.

Wall Street Analyst James Shin

Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) on 7/23/2024. The price target of $45 was fulfilled within 3 days with a profit of $5.83 (14.88%), with a performance score of 49.61.

Average potential price target upside

ABBV AbbVie AMGN Amgen BMY Bristol-Myers Squibb Company GILD Gilead Sciences IMGN ImmunoGen INCY yte LLY Eli Lilly and Company MRK Merck mpany STRO Sutro Biopharma REGN Regeneron Pharmaceuticals ZYME Zymeworks TCRT Alaunos Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Feb-2026

$335

$39.97 (13.55%)

$325

3 days ago
(15-Nov-2026)

Buy Since 17-Nov-2020

$338

$42.97 (14.56%)

$282

17 days ago
(01-Nov-2026)

20/21 (95.24%)

$43.11 (14.62%)

335

Buy Since 07-Dec-2021

$340

$44.97 (15.24%)

$300

17 days ago
(01-Nov-2026)

11/13 (84.62%)

$45.11 (15.30%)

479

Buy Since 05-Apr-2022

$346

$50.97 (17.28%)

$310

17 days ago
(01-Nov-2026)

33/35 (94.29%)

$51.11 (17.33%)

486

Buy Since 15-Nov-2023

$325

$29.97 (10.16%)

$290

17 days ago
(01-Nov-2026)

32/33 (96.97%)

$30.11 (10.21%)

244

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by James Shin?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?